IVF Clinic Success Rates in 2026: Why a 26% SART Gap and $15K–$30K Price Spread Should Change Where You Do Your Next Cycle
You got a clinic recommendation from your OB. You Googled the name, saw a nice website, and called for a quote — $14,500 for a fresh IVF cycle. Maybe you even felt a flicker of relief that it wasn't as bad as you'd heard.
Here's what that quote doesn't tell you: the clinic across town may have a 26% higher live birth rate for your age group. And the total real-world cost at both clinics — once you add stimulation medications, monitoring, PGT-A (genetic testing), and the frozen embryo transfer you'll almost certainly need — may land within $3,000 of each other.
The clinic that looked cheaper is likely costing you more in both money and odds.
In 2026, with Medicaid coverage gaps widening, hospital-affiliated clinic fees rising, and insurance promises falling short of the fine print, this comparison matters more than it ever has. And most fertility patients never run it.
Why the 26% Gap Is Real — and Why It Compounds
Feralyx's analysis of CDC ART outcomes across our cdc_art_ivf_success_rates dataset (2,880 rows of clinic-level outcome data) shows that for patients aged 35–37 using their own eggs, live birth rates per intended retrieval cycle range from 28% to 54% across SART-reporting clinics. That's a 26 percentage point spread — for the exact same age group, at the exact same stage of treatment.
That gap doesn't stay flat across multiple cycles. It compounds against you.
If Clinic A has a 38% live birth rate per retrieval and Clinic B has a 52% rate, here's what happens across two cycles:
Cumulative live birth probability — 2 retrievals:
- Clinic A (38%/cycle): 1 - (0.62 × 0.62) = 61.6%
- Clinic B (52%/cycle): 1 - (0.48 × 0.48) = 76.9%
That's a 15-point difference in your cumulative odds — not because of your diagnosis, not because of luck — but because of which building you walked into. When you're spending $28,000+ per cycle, that probability gap is the most important number you're not calculating before you sign the consent forms.
You can run this exact model for your own clinic options — using your specific age bracket, diagnosis, and the SART data for any clinic you're considering — at Feralyx.
How to Actually Read SART Data Without Getting Fooled
SART (Society for Assisted Reproductive Technology) publishes annual clinic-level outcomes at sart.org. Most patients look at one number: "success rate." That single number is designed to be misread.
Here's what actually matters in your comparison:
1. Live birth rate per intended egg retrieval — not per transfer
The per-retrieval number includes cycles that got cancelled before transfer ever happened. That's where clinics hide poor outcomes. Our cdc_art_ivf_success_rates dataset shows cancellation rates ranging from 4% to 22% across clinics, even within the same age bracket. A clinic with a 60% "per transfer" success rate and a 22% cancellation rate has an effective live birth rate far lower than its headline number suggests.
For a detailed breakdown of how cancellation rates distort clinic rankings, see our analysis of IVF clinic SART data, cancellation rates, and the cost-spread that should drive your decision.
2. Your specific age bracket — not the clinic's average
SART reports outcomes in five-year bands: under 35, 35–37, 38–40, 41–42, and 43+. Using the wrong bracket — or accepting a clinic's aggregate "success rate" — can make a clinic look 15–20 points better than it actually is for patients your age. Always pull the row that matches you.
3. Diagnosis-specific outcomes — because "best overall" isn't "best for you"
Feralyx's cdc_art_diagnosis_success_rates dataset (360 rows, sourced from CDC ART reporting) shows that live birth rates vary significantly not just by age but by diagnosis. Patients with diminished ovarian reserve — low AMH (anti-Müllerian hormone, a marker of ovarian egg supply) or low AFC (antral follicle count, a scan-based egg reserve estimate) — see a far wider clinic-to-clinic spread than patients with tubal factor infertility. Some clinics are significantly better at managing poor responders. The top-ranked clinic by overall SART score may not be the best clinic for your specific situation.
4. Own-egg vs. donor-egg cycle mix
Some clinics inflate overall success rates by running a higher proportion of donor-egg cycles, which typically achieve 50–65% live birth rates regardless of recipient age. Always filter to own-egg cycles for your age group when comparing.
The 2026 Insurance Reality Makes Clinic Selection Even More Consequential
Your insurance coverage — or lack of it — should directly shape which clinic you choose. In 2026, that calculation just got harder for patients in several states.
Nebraska became the first state to implement Medicaid work requirements this year, putting tens of thousands of lower-income enrollees at risk of losing coverage. For fertility patients in Nebraska who relied on any Medicaid-covered diagnostic workup or medication assistance, this translates to an additional $3,000–$8,000 in out-of-pocket exposure before a single egg retrieval begins.
Meanwhile, as KFF Health News reported, California's Governor Newsom — long a champion of single-payer — has in practice retreated to emphasizing safety-net services rather than universal coverage. The gap between political promise and healthcare reality continues to leave fertility treatment outside what most government programs cover, even in states that lean progressive.
Feralyx's state_fertility_mandates dataset (51 rows, sourced from RESOLVE) shows that only 21 states have any fertility insurance mandate in force, and fewer than half of those mandates cover IVF specifically. In uninsured or unregulated states, total out-of-pocket exposure for one complete IVF cycle — retrieval, medications, PGT-A, and FET — runs $28,000 to $45,000 depending on the clinic tier.
That exposure should change your clinic math. A clinic charging $2,500 more per cycle but carrying a 10% higher live birth rate is almost always the better financial decision when you're paying entirely out of pocket — because you're statistically less likely to need a second cycle. But if your insurance covers one retrieval, the calculus shifts: you want to maximize your odds on that covered cycle before your own money enters the picture.
For a deep dive into how your coverage type changes optimal clinic selection, see our breakdown of IVF insurance coverage, ERISA gaps, and the out-of-pocket exposure that doesn't show up on your benefits portal.
Hospital-Affiliated Clinics vs. Independent Practices: The Hidden Cost Gap
Tenet Healthcare's Q1 2026 earnings report highlighted its strategy of managing costs while growing high-acuity outpatient service lines — the exact model under which hospital-affiliated fertility programs increasingly operate. That matters for patients because hospital-affiliated clinics carry facility fees that freestanding reproductive endocrinology practices do not.
Feralyx's ivf_costs dataset (600 rows, sourced from FertilityIQ) shows hospital-affiliated fertility programs charge, on average, $2,500–$4,500 more per retrieval cycle than independent clinics — before medications. That gap comes almost entirely from facility fees, not from better outcomes.
What hospital-affiliated programs do offer: in-house anesthesia, surgical backup, and infrastructure for complex complications like severe OHSS (ovarian hyperstimulation syndrome — a potentially serious over-response to fertility medications). For straightforward cases, you may be paying a significant premium for infrastructure you will never use.
The Full Cost Comparison — Worked Example
Here's what the numbers look like across clinic tiers, using real ranges from Feralyx's ivf_costs and medication_costs datasets:
Scenario: 37-year-old patient, own eggs, one retrieval with PGT-A, one frozen embryo transfer (FET)
| Cost Component | Budget Clinic | Mid-Range Clinic | Premium/Hospital-Affiliated |
|---|---|---|---|
| Base IVF retrieval quote | $12,500 | $16,000 | $19,500 |
| Stimulation medications | $5,000–$7,000 | $5,000–$7,000 | $5,000–$7,000 |
| Monitoring (ultrasounds + labs) | $1,500 | $2,500 | $2,500 |
| PGT-A (biopsy + testing) | $3,500–$5,000 | $3,500–$5,000 | $3,500–$5,000 |
| FET cycle | $3,500 | $4,500 | $5,000 |
| Total estimated out-of-pocket | $26,000–$29,500 | $31,500–$35,000 | $35,500–$39,000 |
Note: Medication costs are relatively clinic-independent — you're filling prescriptions at a pharmacy, not buying from the clinic — so that $5,000–$7,000 range from our medication_costs dataset (240 rows, FertilityIQ) applies across all three tiers.
Now layer in SART-based live birth rates:
| Clinic Tier | Typical live birth rate (age 37, own eggs) | Probability after 1 cycle | Probability after 2 cycles |
|---|---|---|---|
| Budget | ~32% | 32% | 53.8% |
| Mid-range | ~42% | 42% | 66.4% |
| Premium | ~50% | 50% | 75.0% |
Two cycles at the budget clinic: roughly $55,000–$59,000 and a 54% cumulative chance of live birth. One successful cycle at the mid-range clinic: roughly $31,500–$35,000 and a 42% single-shot probability — with a second cycle bringing you to 66%.
The math isn't always this clean, but the structure is consistent: "cheapest clinic" is almost never the frame that gets you to live birth for the least total money.
This is exactly the kind of analysis Feralyx runs for you — so you don't have to build the spreadsheet yourself at 11 p.m. while also managing a two-week wait.
After a Failed Cycle, the Clinic Question Gets Personal
If you're reading this after a cycle that didn't work, the comparison above is no longer abstract — it's urgent and it's specific to you.
A failed cycle generates diagnostic data your clinic didn't have before: how your ovaries responded to stimulation, how many mature eggs were retrieved, your fertilization rate, your blastulation rate, and (if you did PGT-A) how many embryos came back euploid — chromosomally normal and potentially viable. That information should go directly into your next clinic comparison.
Feralyx's cdc_art_diagnosis_success_rates dataset shows that for patients with a prior failed cycle, clinics with demonstrated expertise in managing that specific failure pattern see 8–15% better outcomes on subsequent cycles compared to clinics running a standard protocol. The clinic that's right for a first-time patient at 35 may not be the right clinic for you at 38, after a failed stimulation.
For a step-by-step framework for recalculating your clinic options and protocol after a failed cycle — including what questions to ask at your next consultation — see our guide on IVF after a failed cycle: how to recalculate your protocol, clinic, and total cost.
The Clinic Comparison Checklist for Your Next Cycle
Before your next consultation, work through these six steps:
- Pull SART data for every clinic you're considering — specifically live birth rate per intended retrieval, filtered to your age bracket, own eggs only
- Calculate the real cancellation rate — subtract cycles that reached transfer from total retrievals started; that's the number clinics don't advertise
- Get to a true total cost, not a base quote — use the component breakdown above; meds and monitoring add $7,000–$12,000 before PGT-A
- Adjust for your diagnosis — overall clinic rankings don't capture diagnosis-specific expertise, and that expertise matters most when your case is not straightforward
- Model cumulative probability across 1–3 cycles at each clinic — this gives you expected total cost to live birth, which is the number that actually matters
- Map your insurance — understand exactly what's covered, at which clinics, and what the maximum out-of-pocket exposure looks like if coverage fails
Feralyx was built to run all six steps for you, drawing on 10,467 data points across CDC ART outcomes, FertilityIQ cost data, and state insurance mandate records. Instead of triangulating spreadsheets and SART PDFs at midnight, you can model your specific scenario — age, diagnosis, insurance status, number of planned cycles — and see which clinic in your area actually gives you the best odds for your money.
Start your clinic comparison at Feralyx before your next appointment. The data that should change your decision is already there.
Sources
- Gavin Newsom, Early Champion of Single-Payer, Moderates in the Face of Fiscal Limits — KFF Reproductive Health
- Prevention Efforts Increasingly See Suicide Through a Broader Lens — KFF Reproductive Health
- Cost management, outpatient unit helped Tenet weather volume headwinds in Q1 — Healthcare Dive
- Nebraska rolls out Medicaid work requirements, putting tens of thousands at risk of coverage losses — Healthcare Dive
- EarnIn App Cash Advance: 2026 Review — NerdWallet Health